212 results on '"Nguyen, Rosa"'
Search Results
2. INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults
3. Supplementary Fig. S9 from Cooperative Armoring of CAR and TCR T Cells by T Cell–Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy
4. A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia.
5. Combining selinexor with alisertib to target the p53 pathway in neuroblastoma
6. Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8⁺ T cell stemness and antitumor immunity
7. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice
8. Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastoma
9. Cooperative Armoring of CAR and TCR T Cells by T Cell–Restricted IL15 and IL21 Universally Enhances Solid Tumor Efficacy
10. 621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors
11. Contributors
12. Adoptive NK cell therapies in children with cancer: Clinical challenges and future possibilities
13. Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy
14. Immunotherapy approaches targeting neuroblastoma
15. Treatment-Related Noncontiguous Radiologic Changes in Children With Diffuse Intrinsic Pontine Glioma Treated With Expanded Irradiation Fields and Antiangiogenic Therapy
16. MYCN amplification and ATRX mutations are incompatible in neuroblastoma
17. List of Contributors
18. Neuroblastoma
19. The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma
20. Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
21. Supplementary Data from Anti-GD2 Antibodies Conjugated to IL15 and IL21 Mediate Potent Antitumor Cytotoxicity against Neuroblastoma
22. Figure S3 from Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
23. HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
24. Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
25. Anti-GD2 Antibodies Conjugated to IL15 and IL21 Mediate Potent Antitumor Cytotoxicity against Neuroblastoma
26. A “cooperative collaboration” between HAND2 and MYCN shapes neuroblastoma cell identity
27. Characterization of spinal findings in children and adults with neurofibromatosis type 1 enrolled in a natural history study using magnetic resonance imaging
28. Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models
29. Abstract P164: Identification of the p53 negative feedback loop as a target for enhancing selinexor activity in neuroblastoma
30. Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1
31. Chapter 19 - Adoptive NK cell therapies in children with cancer: Clinical challenges and future possibilities
32. Quantitative associations of scalp and body subcutaneous neurofibromas with internal plexiform tumors in neurofibromatosis 1
33. CD4-BFFI: A novel, bifunctional HIV-1 entry inhibitor with high and broad antiviral potency
34. Question 2: Is a lumbar puncture necessary in an afebrile newborn infant with localised skin and soft tissue infection?
35. Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis
36. A 2-Year-Old Boy With Knee Pain, Fever, and Multiple Birthmarks
37. Considerations for treatment duration in responders to immune checkpoint inhibitors
38. Immunotherapy approaches targeting neuroblastoma
39. Next-generation humanized patient-derived xenograft mouse model for pre-clinical antibody studies in neuroblastoma
40. Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8 + T cell stemness and antitumor immunity
41. Longitudinal NK cell kinetics and cytotoxicity in children with neuroblastoma enrolled in a clinical phase II trial
42. Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma
43. Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Frequency and Associated Clinical Deficits
44. Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions
45. Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1
46. Delineation of the clinical phenotype associated with non-mosaic type-2 NF1 deletions: two case reports
47. MIA is a potential biomarker for tumour load in neurofibromatosis type 1
48. Phenolic content and antioxidant capacity of honey: Influence of botanical and geographical origin
49. Bisphosphonate Use in Pediatric Oncology for Pain Management
50. Stakeholder Engagement In a Comparative Effectiveness/Implementation Study to Prevent Staphylococcus Aureus Infection Recurrence: CA-MRSA Project (CAMP2)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.